Handel międzynarodowy · 5.05.2022

Certain Botulinum Toxin Products and Processes for Manufacturing or Relating to Same; Institution of Investigation

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on March 30, 2022, under section 337 of the Tariff Act of 1930, as amended, on behalf of Medytox Inc. of the Republic of Korea. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain botulinum toxin products and processes for manufacturing or relating to same by reason of theft and conversion and misappropriation of trade secrets, the threat or effect of which is to destroy or substantially injure an industry in the United States. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.